Dr Kate Seib

Dr Seib is a Group Leader at the Institute for Glycomics, Griffith University (Gold Coast). She completed a PhD in microbiology in 2004 from the University of Queensland, spent several years at Novartis Vaccines (Siena, Italy), and returned to Australia in 2012. Herresearch is currently focused on understanding the processes involved in host colonisation and disease, with the aim to identify therapeutic targets of bacterial pathogens including Neisseriagonorrhoeae (causes the sexually transmitted infection gonorrhoea, which can lead to infertility), Neisseriameningitidis (causes sepsis and meningitis)and Moraxellacatarrhalis and non-typeable Haemophilus influenzae (causes middle ear infections and exacerbations of chronic obstructive pulmonary disease).